We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems,... read more Featured Products: More products

Download Mobile App




Discount Cancer Imaging System Developed for Emerging Economies

By MedImaging International staff writers
Posted on 07 Apr 2014
Print article
Image: The Discovery IQ PET-CT device (Photo courtesy of GE Healthcare).
Image: The Discovery IQ PET-CT device (Photo courtesy of GE Healthcare).
GE Healthcare (GE; Chalfont St. Giles, United Kingdom) has developed a discount molecular imaging system for cancer detection, intended for physicians practicing personalized medicine in emerging markets, especially India.

The new Discovery IQ positron emission tomography-computed tomography (PET-CT) device is intended to measure a patient's response to cancer treatment. The device is designed to be paired with cyclotrons in advanced imaging centers to scan the human body and produce bio-markers that can light up cancer cells. Since about 70 % of cancer patients do not respond to their initial chemotherapy treatment, the PET-CT can help physicians determine if the treatment is beneficial with one or two chemotherapy cycles, reducing overall cost per patient.

An advanced molecular imaging center requires a PET-CT; however, setting up of a molecular imaging center is expensive and calls for a large financial investment which has prevented setting up of such early detection technology in India. With the support of several Indian entrepreneurs, GE has built a robust network of cyclotrons throughout India to minimize the investment required to set up a molecular imaging center, resulting in a reduced set-up in an Indian hospital at just INR 300 million [30 crore or about USD 5 million], presenting a significantly more affordable alternative to other systems on the market.

“Three years back, we promised to develop an advanced yet affordable PET-CT to improve access to early cancer detection. We have realized the commitment to provide an advanced PET- CT that is 40% more affordable and can usher in personalized treatment for the patient,” said Terri Bresenham, president and CEO of GE Healthcare South Asia. “We are extremely thankful to the Indian healthcare providers for their close collaboration and insights into their needs that has helped develop this important weapon against cancer.”

“PET/CT can become an integral part of cancer care management for every cancer center in India. Clinicians will now have ready access to tools that will allow evidence based and cost effective treatment. Together with our customers, we are focused on improving access, quality and affordable cancer care for the patient,” added N. R. Balamurugan, director of oncology at GE Healthcare South Asia.

If the biologically active molecule chosen for PET-CT is fludeoxyglucose (FDG), an analogue of glucose, the concentrations of tracer imaged will indicate tissue metabolic activity by virtue of the regional glucose uptake. Use of this tracer to explore the possibility of cancer metastasis is the most common type of PET scan in standard medical care (90% of current scans).

Related Links:

GE Healthcare 


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Thyroid Shield
Standard Thyroid Shield
New
Ultrasound System
Acclarix AX9
Laptop Ultrasound Scanner
PL-3018

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.